Basic information of IFNA17 :
| Official Symbol of Gene | IFNA17 |
| Species | Homo sapiens |
| Entrez Gene ID | 3451 |
| Official Full Name | interferon alpha 17 |
| Also known as | IFNA; INFA; LEIF2C1; IFN-alphaI |
| Gene Type | protein coding |
| dbXrefs | Ensembl:ENSG00000234829 MIM:147583; AllianceGenome:HGNC:5422 |
| Map Location | 9p21.3 |
| Variation Type | polymorphism |
| refSNP ID | N/A |
Sample information of multiple sclerosis:
| Detected Sample | blood |
| Sample Detail | N/A |
| Detected Method | PCR |
| Disease | MS |
| Disease subtype | PPMS |
| Population | the Northern Sweden Health and Disease Study (NSHDS) Cohort |
| Sample Size | 399 MS cases;Referents (n=698) |
Literature information of multiple sclerosis :
| Pubmed ID | 17956450 |
| Year | 2007 |
| Title | No support for a truncated interferon-alpha 17 allele as risk factor for MS |
Results of multiple sclerosis :
| Risk Type | disease risk |
| Main Result | Negative |
| Result | Thus, our study does not support an association between the IFNA17 allele and risk for MS. |
| Mechanism/Pathway | The finding, based on eight PPMS cases being positive for the allele whilst none of the referents were, may therefore be a post hoc type 1 error. |
